In the modern era of healthcare, the Global Breast Health Screening Industry has transitioned from reactive treatment to proactive prevention. Breast cancer remains the most prevalent cancer among women worldwide, contributing to over 2.3 million new cases annually. Consequently, the commercial demand for high-precision, non-invasive screening technologies—ranging from AI-enhanced thermography to digital mammography and smart wearables—has surged. Governments and private healthcare providers across Europe, North America, and Southeast Asia are increasingly investing in population-wide screening programs to reduce mortality rates through early detection.
The global market for breast imaging is projected to reach USD 7.3 billion by 2028. This growth is driven by rising awareness and the integration of AI-driven diagnostic tools that minimize human error.
Traditional clinics are migrating toward "Point-of-Care" (POC) testing and telemedicine kiosks, allowing for rapid screening in remote or underserved urban areas.
Global buyers now demand ISO-certified manufacturing and biocompatible materials, ensuring that screening devices meet rigorous safety standards for clinical use.
The industry is currently witnessing a paradigm shift powered by Artificial Intelligence and the Internet of Medical Things (IoMT). As a premier OEM/ODM Breast Health Screening Factory, we stay at the forefront of these trends to provide our clients with competitive market advantages.
One of the most significant trends is the integration of screening tools into multi-functional telemedicine kiosks. These hubs allow for decentralized health monitoring. Our Preventive Health Screening Telemedicine Kiosk serves as a prime example, combining thermal imaging sensors with real-time data analysis to provide immediate health insights.
The move toward "Hospital-at-Home" models means that manufacturers must now focus on portability and ease of use without sacrificing clinical accuracy.
Screening data is no longer siloed. Cloud-based platforms now aggregate screening results to predict regional health trends and optimize hospital resource allocation.
Non-radiation based screening methods are gaining traction among health-conscious consumers, particularly as a secondary monitoring tool alongside traditional mammography.
B2B procurement for breast health screening equipment has become highly specialized. From NGOs in Africa to high-end private medical groups in Dubai, the requirements vary but the core needs remain: reliability, cost-efficiency, and scalability.
Large enterprises are implementing on-site health kiosks to provide employees with annual breast health screenings, improving employee retention and reducing long-term insurance costs.
In developing regions, mobile screening units equipped with our ODM technology allow healthcare workers to reach women who lack access to centralized hospitals.
Brands focusing on female wellness are expanding their product lines to include both screening services and targeted nutritional support.
As a leading Chinese factory based in Shenzhen—the Silicon Valley of Hardware—we offer unparalleled advantages in the MedTech sector. Our ability to blend rapid prototyping with mass-market manufacturing ensures that our clients stay ahead of the curve.
We understand that screening is just one part of the journey. To support long-term breast health, we also provide OEM services for All-in-One Supplement Complex Nutrients Vitamin Packs. These products are designed to support hormonal balance and overall female vitality, providing a 360-degree approach to women's health that our B2B clients can market as a complete package.
Founded in 2015, Met Health has become a leading manufacturer specializing in smart wearable devices. With over a decade of expertise in research and development, production, and management, we focus on delivering innovative solutions in senior health management, disease monitoring, and personal safety.
Our state-of-the-art production facility in Shenzhen is equipped with advanced production lines and precision equipment, ensuring high-quality manufacturing standards. As an ISO9001-certified company, we maintain stringent quality control throughout the production process.
Production Capacity: We produce over 100,000 units per month, enabling us to meet the demands of global markets.
Supply Chain: Strong partnerships with material suppliers ensure cost efficiency and timely delivery.
We offer tailored solutions to meet specific customer needs, combining cutting-edge technology with expert craftsmanship to deliver world-class wearable products.
Specializing in senior health, disease monitoring, and personal safety with 10+ years of R&D.
ISO9001-certified facility in Shenzhen with precision equipment and reliable QC.
Looking ahead, the integration of 5G connectivity and edge computing will revolutionize the screening industry. Imagine a world where a wearable patch can monitor breast tissue changes in real-time and alert the user via a smartphone app. This is the future Met Health is building. We are currently developing next-generation ODM sensors that are thinner, more sensitive, and more affordable, making breast health screening a daily habit rather than a yearly ordeal.
Our commitment to "Technology with Heart" ensures that every device we manufacture is built with the end-user in mind—balancing professional medical accuracy with the comfort and privacy that women deserve.
Met Health
